BPC-157 + TB-500
In Stock
For laboratory research use onlyBPC-157 + TB-500 is supplied as a lyophilised powder in two strengths, 10 mg and 20 mg per vial, ten vials to a box. Each vial is a blend of BPC-157 and TB-500 combined. This batch has been analysed by Janoshik Analytical, an independent laboratory. The report is reproduced in full under the Lab Test tab above and can be verified using the key printed on it.
Specification
| Product name | BPC-157 + TB-500 |
|---|---|
| Pack sizes | 10 mg × 10 vials 20 mg × 10 vials |
| Presentation | Lyophilised powder |
| Measured content | BPC-157 5.73 mg and TB-500 5.36 mg in the 10 mg vial |
| Third-party testing | Janoshik Analytical — 1 report on file |
Storage and handling
Store sealed vials in a cool, dry place, away from direct light and heat.
All products are for laboratory research use only and are not for human or veterinary use.
Every batch is sent to Janoshik Analytical, an independent third-party laboratory. Each report below can be checked at janoshik.com/verify using the unique key printed at the bottom of it.
View full report0.00
Average of 0 reviews
Related Products
Discover similar pieces designed to complement your space and style.
Fast & Reliable Delivery
Delivered with care and on time.
Dedicated Support
Our team is here to assist you.
Premium Quality
Carefully crafted products made.
Easy Returns
Simple and hassle-free return process.
We use cookies to improve your experience. By continuing, you agree to our cookie policy.
I AcceptYour Cart
Add $500.00 more to get free shipping!
Adipotide
Price range: $210.00 through $230.00
Tesamorelin
Price range: $136.00 through $257.00
Make up the difference
Price range: $2.00 through $1,000.00
GLOW70(BPC157 10mg+GHKCU 50mg+TB500 10mg)
Original price was: $280.00.$256.00Current price is: $256.00.
BPC-157 + TB-500
All Categories
Search
Adipotide
Price range: $210.00 through $230.00Tesamorelin
Price range: $136.00 through $257.00Make up the difference
Price range: $2.00 through $1,000.00
Reviews
There are no reviews yet.